Given that sLRIG3 is released from glioma cells overexpressing LRIG3 and can be detected in serum and glioma cystic fluid samples of patients, we further investigated the functions of LRIG3 and sLRIG3 in gliomas. Here, LRIG3 is linked to central nervous system cancer.